4
Changes in Ownership
Scribe Therapeutics, Inc. Filed Acc 0000902664-26-003254
Options or other derivatives
- Director acquired 14,725 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Aghazadeh Behzad Director | 2026-07-23 | Grant or award · Stock Option (Right to Buy) | +14,725 | 14,725 | D | ||
Loading xslF345X06/ownership.xml…